Natixis Advisors LLC Purchases Shares of 19,738 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […]
Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […]
